EBITDA (Quarterly)

EBITDA: Income before interest, taxes, depreciation and amortization.

Bio-Rad Laboratories, Inc. (BIO.B) had EBITDA of $72.60M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$651.00M
Net Income	$371.40M
Cost of Goods Sold	$305.20M
Gross Profit	$345.80M
Operating Expenses	$578.40M
Operating Income	$72.60M
Non-Operating Income/Expense	$469.50M
Pre-Tax Income	$542.10M
Normalized Pre-Tax Income	$84.10M
Income after Taxes	$371.40M
Income from Continuous Operations	$371.40M
Consolidated Net Income/Loss	$371.40M
Normalized Income after Taxes	$-230.82M
EBIT	$72.60M
EBITDA	$72.60M
Weighted-Average Shares Outstanding (Basic)	26.75M
Weighted-Average Shares Outstanding (Diluted)	26.81M
Earnings per Share (EPS) (Basic)	$13.89
Earnings per Share (EPS) (Diluted)	$13.85
Balance Sheet Financials
Current Assets	$3.02B
Property, Plant, and Equipment	$517.90M
Long-Term Assets	$7.23B
Total Assets	$10.25B
Current Liabilities	$961.30M
Long-Term Debt	$803.00M
Long-Term Liabilities	$2.12B
Total Liabilities	$3.08B
Common Equity	$7.17B
Tangible Shareholders Equity	$6.44B
Shareholders Equity	$7.17B
Common Shares Outstanding	26.74M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$206.80M
Cash Flow from Investing Activities	$-159.90M
Cash Flow from Financial Activities	$-71.60M
Beginning Cash	$532.20M
End Cash	$518.80M
Increase/Decrease in Cash	$-13.40M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.14
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.10
Debt to Equity Ratio	0.17
Gross Margin	53.12%
Operating Margin	11.15%
EBIT Margin	11.15%
EBITDA Margin	--
Pre-Tax Profit Margin	83.27%
Profit Margin	57.05%
Free Cash Flow	$144.80M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.06
Inventory Turnover	0.39
Receiveable Turnover	1.47
Days Sales in Receivables	61.08
Return on Equity	5.18%
Return on Tangible Equity	5.77%
Return on Assets	3.62%
Return on Investments	4.66%
Book Value Per Share	$268.30
Free Cash Flow per Share	$5.40
Operating Cash Flow per Share	$7.71

Data from Zacks Investment Research, Inc.